Ann: Program Development Progress Report, page-24

Well, if your holding in a company has been heavy diluted for a reasons yet to be determined (apart from paying more staff for projects that arent even confirmed) and this is what we get, than yes, we have a right to be extremely disappointed and frustrated.

remember this time last year we here were all excited about gsk oral clinical trials and how it was going to be the making of us, now, nothing. is bodyguard this years gsk? rinse and repeat?
i feel very angry at myself for what has happened with this company, genuine bandits at this stage until proven otherwise.